Cargando…
Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions
Vaccine-induced immune thrombotic thrombocytopenia (VITT) (also termed thrombosis with thrombocytopenia syndrome or vaccine-induced thrombotic thrombocytopenia or vaccine-induced immune thrombocytopenia) is characterized by (i) venous or arterial thrombosis; (ii) mild-to-severe thrombocytopenia; (ii...
Autores principales: | Marchandot, Benjamin, Curtiaud, Anais, Trimaille, Antonin, Sattler, Laurent, Grunebaum, Lelia, Morel, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385852/ https://www.ncbi.nlm.nih.gov/pubmed/35915769 http://dx.doi.org/10.1093/ehjopen/oeab014 |
Ejemplares similares
-
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
por: Marchandot, Benjamin, et al.
Publicado: (2021) -
Microparticles in COVID-19 as a link between lung injury extension and thrombosis
por: Morel, Olivier, et al.
Publicado: (2021) -
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
por: Marchandot, Benjamin, et al.
Publicado: (2020) -
Acute Pulmonary Embolism in Patients with and without COVID-19
por: Trimaille, Antonin, et al.
Publicado: (2021) -
D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients
por: Trimaille, Antonin, et al.
Publicado: (2020)